In This Article:
How much a stock's price changes over time is important for most investors, since price performance can both impact your investment portfolio and help you compare investment results across sectors and industries.
FOMO, or the fear of missing out, also plays a role in investing, particularly with tech giants and popular consumer-facing stocks.
What if you'd invested in DexCom (DXCM) ten years ago? It may not have been easy to hold on to DXCM for all that time, but if you did, how much would your investment be worth today?
DexCom's Business In-Depth
With that in mind, let's take a look at DexCom's main business drivers.
San Diego, CA-based DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients.
A key element of DexCom’s monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company’s monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels.
Going by an article of Research and Markets, the blood glucose monitoring devices market is expected to witness a CAGR of over 9% between 2018 and 2024.
DexCom has collaborative agreements with several companies, which should not only bring in cash in the form of milestone payments and royalties but should also help expand its product use. It is also focusing on international markets
However, market for blood glucose monitoring devices is highly competitive, subject to rapid change and significantly affected by new product introductions.
2022 at a Glance
For the full-year 2022, the company reported adjusted EPS of 87 cents, up 77.6% from 2021. Full-year 2022 revenues came in at $2.91 billion, up 19% year over year.
Revenues in the United States were up 16%. International revenues were up 28% and 31% reportedly and organically, respectively.
Bottom Line
Anyone can invest, but building a successful investment portfolio requires research, patience, and a little bit of risk. So, if you had invested in DexCom ten years ago, you're likely feeling pretty good about your investment today.
According to our calculations, a $1000 investment made in June 2013 would be worth $21,887.46, or a 2,088.75% gain, as of June 28, 2023. Investors should keep in mind that this return excludes dividends but includes price appreciation.